Sudhesh Kumar
 professor
                            School of Medicine                                                        
The University of Warwick
                                                        United Kingdom
                        
Biography
Professor Sudhesh Kumar is Dean of the Warwick Medical School and Director of the Institute of Digital Healthcare at University of Warwick. In addition to these roles, he is also a member of the Coventry & Rugby Health and Wellbeing Board, and the Medical Schools Council. He is a clinical endocrinologist by background with 22 years experience as a Consultant Physician in the NHS. His research interest is obesity and its complications, particularly Type 2 diabetes. His interests include developing novel approaches to managing obesity and diabetes that has helped to transform and improve patient care and treatment. He has published over 240 papers and 6 books on these subjects.
Research Interest
1. Pathogenesis of obesity driven diabetes and the metabolic syndrome. My group uses multi-method approaches that integrates clinical and laboratory-based studies to elucidate the molecular basis of obesity-driven diabetes and aims to determine the molecular basis of the link between adiposity and its metabolic and cardiovascular complications. 2. The molecular basis of obesity and body fat distribution, investigating control of energy metabolism and factors regulating the distribution of body fat in different adipose tissue depots. 3. Novel approaches to the treatment of obesity and type 2 diabetes incorporating new behavioural, dietary and pharmacological approaches, including early intervention to prevent type 2 diabetes.
Publications
- 
                            
Reddy NL, Peng C, Carreira MC, Halder L, Hattersley J, Piya MK, Tripathi G, Randeva HS, Casanueva FF, McTernan PG, Kumar S. Enhanced thermic effect of food, postprandial NEFA suppression and raised adiponectin in obese women who eat slowly. Clinical endocrinology. 2015 Jun 1;82(6):831-7.
 - 
                            
Montvida O, Klein K, Kumar S, Khunti K, Paul SK. Addition of or switch to insulin therapy in people treated with glucagonâ€like peptideâ€1 receptor agonists: A realâ€world study in 66 583 patients. Diabetes, Obesity and Metabolism. 2017 Jan 1;19(1):108-17.
 - 
                            
Aroda VR, Bailey TS, Cariou B, Kumar S, Leiter LA, Raskin P, Zacho J, Andersen TH, Philisâ€Tsimikas A. Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a doubleâ€blind randomized controlled trial (BEGIN: ADD TO GLPâ€1 Study). Diabetes, Obesity and Metabolism. 2016 Jul 1;18(7):663-70.